Ir.ipatherapeutics.com is a subdomain of Ipatherapeutics.com, which was created on 2022-02-18,making it 2 years ago.
Discover ir.ipatherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 98.337 KB |
Page Load Time: 0.121377 Seconds |
Website IP Address: 162.159.130.11 |
Masonite International Corp. - Investor Relations - Investor Relations investor.masonite.com |
Block, Inc. (SQ) Investor Relations - Investor Relations investors.block.xyz |
Gen Investor Relations - Investor Relations investor.gendigital.com |
MindChamps PreSchool Limited - Investor Relations: Investor Relations investor.mindchamps.org |
Home - Ayala Land Investor Relations : Ayala Land Investor Relations ir.ayalaland.com.ph |
Universal Technical Institute's Investor Relations - UTI Investor Relations uti.investorroom.com |
Ameriprise Financial Investor Relations | Investor Relations ir.ameriprise.com |
Meridian Bank Investor Relations - Meridian Bank Investor Relations investor.meridianbanker.com |
Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations ir.armstrong.com |
Walmart Investor Relations - Investor Relations stock.walmart.com |
Alphabet Investor Relations - Investor Relations - Alphabet investor.google.com |
Investor Relations | Jacobs - Investor Relations invest.jacobs.com |
Investor Relations - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/overview/default.aspx |
Financials - Quarterly Results - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/financials/quarterly-results/default.aspx |
Stock Info - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/stock-info/default.aspx |
News Releases - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/news/news-releases/default.aspx |
Governance Documents - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/governance/governance-documents/default.aspx |
Financials - Annual Reports https://ir.ipatherapeutics.com/financials/annual-reports/default.aspx |
Events & Presentations - ImmunoPrecise Antibodies Ltd. https://ir.ipatherapeutics.com/events-and-presentations/default.aspx |
Governance - Committee Composition https://ir.ipatherapeutics.com/governance/committee-composition/default.aspx |
Resources - Investor Contacts https://ir.ipatherapeutics.com/resources/investor-contacts/default.aspx |
IPA Reports Financial Results and Recent Business Highlights for Third ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fis |
IPA Reports Financial Results and Recent Business Highlights for Second ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fi |
IPA Reports Financial Results and Recent Business Highlights for Second ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2022/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fi |
ImmunoPrecise Reports Financial Results and Recent Business Highlights ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fi |
IPA Announces Closing of $1.265 Million Public Offering of Common ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Announces-Closing-of-1.265-Million-Public-Offering-of-Common-Shares/default.as |
IPA to Report Financial Results and Recent Business Highlights for ... https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter- |
Date: Tue, 14 May 2024 08:26:47 GMT |
Content-Type: text/html; charset=utf-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
CF-Ray: 8839815e88728404-LAX |
CF-Cache-Status: REVALIDATED |
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
Last-Modified: Tue, 14 May 2024 08:26:47 GMT |
Strict-Transport-Security: max-age=31536000; includeSubDomains |
Vary: Accept-Encoding |
X-Content-Type-Options: nosniff |
X-Frame-Options: SAMEORIGIN |
X-XSS-Protection: 1; mode=block |
Server: cloudflare |
content="text/html; charset=utf-8" http-equiv="Content-type"/ |
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
content="XZHBpW-cPfPYXgkaDdwzIP8uWtZysn790gGX1tV9Y6g" name="google-site-verification"/ |
Overview News News Releases In the Media Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Overview News News Releases In the Media Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Corporate Overview IPA’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in IPA, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery. Learn more Latest News View All News in French Latest Events View All View All Follow us follow us on twitter follow us on linkedin follow us on facebook IR Contact Lorem ipsum dolor Position000-0000-0000[email protected] Main Website https://www.ipatherapeutics.com/ Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At ImmunoPrecise Antibodies Ltd., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to ImmunoPrecise Antibodies Ltd. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings EOD Stock Quote Unsubscribe Email Alert Sign Up Confirmation Request a meeting with management Privacy Policy Cookies Policy Terms of Use ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. Powered By Q4 Inc. 5.122.0.3 (opens in new...
Domain Name: IPATHERAPEUTICS.COM Registry Domain ID: 2676176966_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-03T07:11:55Z Creation Date: 2022-02-18T21:16:55Z Registry Expiry Date: 2027-02-18T21:16:55Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T23:18:02Z <<<